SARANEA: A Freely Available Program To Mine Structure−Activity and Structure−Selectivity Relationship Information in Compound Data Sets-Reference-Cited by-同舟云学术

SARANEA: A Freely Available Program To Mine Structure−Activity and Structure−Selectivity Relationship Information in Compound Data Sets

Published:2010-01-07 Issue:1 Volume:50 Page:68-78
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Lounkine Eugen¹,Wawer Mathias¹,Wassermann Anne Mai¹,Bajorath Jürgen¹

Affiliation:

1. Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Dahlmannstrasse 2, D-53113 Bonn, Germany

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci900416a

Reference20 articles.

1. Chemogenomic approaches to rational drug design

2. Systematic computational analysis of structure–activity relationships: concepts, challenges and recent advances

3. Navigating structure–activity landscapes

4. Computational analysis of ligand relationships within target families

5. From Structure-Activity to Structure-Selectivity Relationships: Quantitative Assessment, Selectivity Cliffs, and Key Compounds

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MolCompass: multi-tool for the navigation in chemical space and visual validation of QSAR/QSPR models;Journal of Cheminformatics;2024-08-12

2. Enhancing hERG Risk Assessment with Interpretable Classificatory and Regression Models;Chemical Research in Toxicology;2024-05-23

3. Cheminformatics and artificial intelligence for accelerating agrochemical discovery;Frontiers in Chemistry;2023-11-29

4. Multitask learning-driven identification of novel antitrypanosomal compounds;Future Medicinal Chemistry;2023-08

5. Antileishmanial activity of 5-nitroindazole derivatives;Therapeutic Advances in Infectious Disease;2023-01